Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

Marijke B. Coomans*, Linda Dirven, Neil K. Aaronson, Brigitta G. Baumert, Martin Van Den Bent, Andrew Bottomley, Alba A. Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia, Ulrich Herrlinger, Florence Keime-Guibert, Annika Malmstroem, Francesca Martinelli, Roger Stupp, Andrea Talacchi, Michael Weller, Wolfgang Wick, Jaap C. Reijneveld, Martin J. B. Taphoorn

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1447-1457
Number of pages11
JournalNeuro-oncology
Volume21
Issue number11
DOIs
Publication statusPublished - Nov 2019

Keywords

  • EORTC QLQ-C30
  • glioma
  • health-related quality of life
  • QLQ-BN20
  • symptom
  • symptom cluster
  • QUALITY-OF-LIFE
  • TEMOZOLOMIDE CHEMOTHERAPY
  • EUROPEAN-ORGANIZATION
  • CLINICAL-TRIALS
  • CANCER-PATIENTS
  • OPEN-LABEL
  • RADIOTHERAPY
  • GLIOBLASTOMA
  • REHABILITATION
  • SURVIVAL

Cite this